Ampio Pharmaceuticals, Inc. (AMPE)

OTCMKTS: AMPE · Delayed Price · USD
0.273
-0.072 (-20.87%)
Dec 5, 2022 4:00 PM EST - Market closed
-20.87%
Market Cap 5.20M
Revenue (ttm) n/a
Net Income (ttm) -20.34M
Shares Out 15.07M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 262,594
Open 0.31
Previous Close 0.345
Day's Range 0.264 - 0.34
52-Week Range 0.02 - 1.12
Beta 1.60
Analysts Sell
Price Target 2.04 (+647.3%)
Earnings Date Nov 28, 2022

About AMPE

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical tria... [Read more]

Industry Pharmaceuticals
CEO Michael Macaluso
Employees 9
Stock Exchange NYSEAMERICAN
Ticker Symbol AMPE
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for AMPE stock is "Sell." The 12-month stock price forecast is 2.04, which is an increase of 647.25% from the latest price.

Price Target
$2.04
(647.25% upside)
Analyst Consensus: Sell
Stock Forecasts

News

Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension

ENGLEWOOD, Colo. , Nov. 17, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE) (the "Company") received notification from NYSE American LLC ("NYSE American" or the "Exchange...

2 weeks ago - PRNewsWire

Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split

Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), announced today that effective November 9, 2022 at 4:01 p.m. Eastern Time, the Company will amend its certificate of incorporation to implemen...

3 weeks ago - PRNewsWire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit ...

NEW YORK , Oct. 19, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ampio Pharmaceuticals, Inc.. Shareholders who purchased shares of AMPE during the class period ...

1 month ago - PRNewsWire

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Co...

Los Angeles, California--(Newsfile Corp. - October 17, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceutica...

1 month ago - Newsfile Corp

AMPE DEADLINE TODAY: ROSEN, A TOP RANKED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Bef...

New York, New York--(Newsfile Corp. - October 17, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (OTC Pink: AMPE) bet...

1 month ago - Newsfile Corp

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,...

LOS ANGELES, CA / ACCESSWIRE / October 17, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Am...

1 month ago - Accesswire

Ampio Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 17, 2022 to Discuss Your...

New York, New York--(Newsfile Corp. - October 16, 2022) - Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) of a class action securities law...

1 month ago - Newsfile Corp

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE

New York, New York--(Newsfile Corp. - October 16, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) ("Ampio" or the "Company"). Such invest...

1 month ago - Newsfile Corp

AMPE DEADLINE TOMORROW: ROSEN, skilled investor counsel, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses...

NEW YORK , Oct. 16, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (OTC: AMPE) between December 29, 2020...

1 month ago - PRNewsWire

Ampio Pharmaceuticals Issues Letter to Stockholders

Proposal to Authorize Reverse Stock Split has Been Approved ENGLEWOOD, Colo. , Oct. 14, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), today released the following lett...

1 month ago - PRNewsWire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Phar...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R.

1 month ago - Business Wire

MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,0...

Los Angeles, California--(Newsfile Corp. - October 14, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceutica...

1 month ago - Newsfile Corp

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

NEW YORK , Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Ampio Pharmaceuticals, Inc. (NYSE: AMPE). To rec...

1 month ago - PRNewsWire

AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud Lawsuit

LOS ANGELES , Oct. 13, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agains...

1 month ago - PRNewsWire

MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100...

Los Angeles, California--(Newsfile Corp. - October 13, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ampio Pharmaceutica...

1 month ago - Newsfile Corp

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upc...

NEW YORK , Oct. 13, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) of a class action securities lawsuit. CLASS DEFIN...

1 month ago - PRNewsWire

Ampio Class Action: Levi & Korsinsky Reminds Ampio Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsui...

New York, New York--(Newsfile Corp. - October 12, 2022) - Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) of a class action securities law...

1 month ago - Newsfile Corp

ROSEN, Global Investor Counsel, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important D...

New York, New York--(Newsfile Corp. - October 9, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE)...

1 month ago - Newsfile Corp

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE

New York, New York--(Newsfile Corp. - October 8, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (OTC Pink: AMPE). Such inv...

1 month ago - Newsfile Corp

ROSEN, LEADING INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important ...

NEW YORK , Oct. 7, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) between December...

1 month ago - PRNewsWire

Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings

ENGLEWOOD, Colo. , Oct. 4, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") received written notification from NYSE American LLC ("NYSE American" or the "Exchange")...

2 months ago - PRNewsWire

AMPE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on B...

NEW YORK , Oct. 4, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) alleging that the ...

2 months ago - PRNewsWire

NYSE American to Suspend Trading Immediately in Ampio Pharmaceuticals, Inc. (AMPE) and Commence Delisting Proceedings

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Am...

2 months ago - Business Wire

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Ampio Investors of a Lead Plaintiff Deadline of October 17...

NEW YORK , Oct. 3, 2022 /PRNewswire/ -- Attention Ampio Pharmaceuticals, Inc. ("Ampio") (NYSE: AMPE) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on b...

2 months ago - PRNewsWire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important ...

New York, New York--(Newsfile Corp. - October 1, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE)...

2 months ago - Newsfile Corp